Skip to content
← Back to this collection

PUBLICATIONS · 20843246

Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2010 Sep 16
First author
Verstovsek S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2010 Sep 16;363(12):1180-2. doi: 10.1056/NEJMe1005856.
    note
    Source null
    related pmid
    20843255
    relationship
    Comment in
  2. citation
    N Engl J Med. 2010 Dec 16;363(25):2464; author reply 2464-5; discussion 2465. doi: 10.1056/NEJMc1011635.
    note
    Source null
    related pmid
    21158663
    relationship
    Comment in

Authors and identifiers

  1. name
    Verstovsek S
    type
    Author
  2. name
    Kantarjian H
    type
    Author
  3. name
    Mesa RA
    type
    Author
  4. name
    Pardanani AD
    type
    Author
  5. name
    Cortes-Franco J
    type
    Author
  6. name
    Thomas DA
    type
    Author
  7. name
    Estrov Z
    type
    Author
  8. name
    Fridman JS
    type
    Author
  9. name
    Bradley EC
    type
    Author
  10. name
    Erickson-Viitanen S
    type
    Author
  11. name
    Vaddi K
    type
    Author
  12. name
    Levy R
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Verstovsek S
    type
    Author
  2. name
    Kantarjian H
    type
    Author
  3. name
    Mesa RA
    type
    Author
  4. name
    Pardanani AD
    type
    Author
  5. name
    Cortes-Franco J
    type
    Author
  6. name
    Thomas DA
    type
    Author
  7. name
    Estrov Z
    type
    Author
  8. name
    Fridman JS
    type
    Author
  9. name
    Bradley EC
    type
    Author
  10. name
    Erickson-Viitanen S
    type
    Author
  11. name
    Vaddi K
    type
    Author
  12. name
    Levy R
    type
    Author
bibliography ids
  1. nci-bib-3ca8ec065cf17be5d6f850d2
book metadata
content sha256
246296801aa626ac88ce4bcde30a168b91117fb89e17c1da28f3c7f53269842d
document type
citation
dois
  1. 10.1056/NEJMoa1002028
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:20843246
immutable id
pubmed:20843246@246296801aa626ac88ce4bcde30a168b91117fb89e17c1da28f3c7f53269842d
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
12
name
The New England journal of medicine
nlm unique id
0255562
pages
1117-27
volume
363
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2010 Sep 16;363(12):1180-2. doi: 10.1056/NEJMe1005856.
    note
    Source null
    related pmid
    20843255
    relationship
    Comment in
  2. citation
    N Engl J Med. 2010 Dec 16;363(25):2464; author reply 2464-5; discussion 2465. doi: 10.1056/NEJMc1011635.
    note
    Source null
    related pmid
    21158663
    relationship
    Comment in
outcomes validated
false
pmid
20843246
provenance
batch id
10a38257e12e9ed1867a
provider
NCBI PubMed ESummary
record sha256
92a587a9d5770d05ba9fb3177760218d8325fe1c1d8c737ff73107cc1f5aaaf6
response sha256
84c4808ca38b35d999cfdf809eb088835175ab38d71586c626096d677096bbcc
retrieved at
2026-09-09T23:46:35.793530+00:00
publication date
display
2010 Sep 16
precision
day
year
2010
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/20843246/
title
Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis.

Preserved source evidence · Not medical advice